In patients with symptom resolution of C. difficile infection after treatment with standard-of-care antibiotics, oral administration of...

As understanding of the human microbiome improves, novel therapeutic targets to improve human health with microbial therapeutics will...

Fecal microbiota transplantation (FMT) is increasingly being performed for Clostridium difficile infection in solid organ transplant...

Fecal microbiota transplant (FMT) appears safe and effective for treatment of recurrent Clostridium difficile infection (RCDI). However,...

Hematopoietic stem cell transplant (HSCT) recipients represent a high- risk group for developing Clostridium difficile infection (CDI). ...

Fecal microbiota transplantation (FMT) has been shown to be safe and efficacious in individuals with refractory Clostridium difficile. It...

Clostridium difficile infection has been associated with negative outcomes in the general population and in pregnant patients. Fecal...

Fecal microbiota transplant (FMT) is recommended for Clostridium difficile infection (CDI) treatment; however, use in solid organ...

An 83-year-old female had a 25-year history of recurrent urinary tract infections (UTIs) presented to our infectious disease clinic with...

Antibiotic resistance is a growing emergency due to globalization and widespread antibiotic use. New antibiotics are not being developed...